These percentages are smaller than a recently published study by Sasaki et al., which identified 17% of grade 2 meningiomas with CDKN2A loss by FISH [12% (3/26) and 67% (2/3) of grade 3] [11]. The gene discussed is CDKN2A; the disease is meningioma.